GlassScriptPhysician profile
Stephen G Swanson
NPI 1619963931
$1,360.92
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $950 · 2020: $91.30 · 2021: $206 · 2023: $56.90 · 2024: $56.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $113.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $628.00 | 2019 | |
| Abbvie INC. | $323.84 | 2019-2024 | |
| Astellas Pharma US INC | $137.02 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.23 | 2019-2021 | |
| Allergan, INC. | $88.37 | 2019-2021 | |
| Therapeuticsmd, INC. | $24.12 | 2019 | |
| Agile Therapeutics, INC. | $18.09 | 2021 | |
| Amgen INC. | $17.59 | 2019 | |
| Merck Sharp & Dohme LLC | $16.93 | 2019 | |
| Boston Scientific Corporation | $13.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.